Visceral obesity and cardiometabolic risks: lessons from the VACTION.J study

References

• Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 256, 2823–2828 (1986).
   Google Scholar
• Yusuf S, Hawken S, Ounpuu S et al.; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364, 937–952 (2004).
   Google Scholar
• Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37, 1595–1607 (1988).
   Google Scholar
• Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch. Intern. Med. 149, 1514–1520 (1989).
   Google Scholar
• DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14, 173–194 (1991).
   Google Scholar
• Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 36, 54–59 (1987).
   Google Scholar
• Kissebah AH, Vydelingum N, Murray R et al. Relation of body fat distribution to metabolic complications of obesity. J. Clin. Endocrinol. Metab. 54, 254–260 (1982).
   Google Scholar
• Björntorp P. Classification of obese patients and complications related to the distribution of surplus fat. Am. J. Clin. Nutr. 45, 112–125 (1987).
   Google Scholar
• Nakamura T, Tusbono Y, Kameda-Takemura K et al. Group of the research for the association between host origin and atherosclerotic diseases under the preventive measure for work-related diseases of the Japanese labor ministry. Jpn Circ. J. 65, 11–17 (2001).
   Google Scholar
• Lovejoy JC, de la Bretonne JA, Klemperer M, Tulley R. Abdominal fat distribution and metabolic risk factors: effects of race. Metabolism 45, 1119–1124 (1996).
   Google Scholar
• Després JP, Couillard C, Gagnon J et al. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. Arterioscler. Thromb. Vasc. Biol. 20, 1932–1938 (2000).
   Google Scholar
• Gill TP. Cardiovascular risk in the Asia–Pacific region from a nutrition and metabolic point of view: abdominal obesity. Asia Pac. J. Clin. Nutr. 10, 85–89 (2001).
   Google Scholar
• WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363(9403), 157–163 (2004) Erratum in: Lancet 363(9412), 902 (2004).
   Google Scholar
• Kadowaki T, Sekikawa A, Murata K et al. Japanese men have larger areas of visceral adipose tissue than caucasian men in the same levels of waist circumference in a population-based study. Int. J. Obes. (Lond.) 30, 1163–1165 (2006).
   Google Scholar
• Tokunaga K, Matsuzawa Y, Ishikawa K, Tarui S. A novel technique for the determination of body fat by computed tomography. Int. J. Obes. 7, 437–445 (1983).
   Google Scholar
• Alberti KG, Zimmet P, Shaw J. Metabolic syndrome – a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet. Med. 23, 469–480 (2006).
   Google Scholar
• Després JP, Lemieux I, Bergeron J et al. VACATION-J. Arterioscler. Thromb. Vasc. Biol. 28, 1039–1049 (2008).
   Google Scholar
• Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 444, 881–887 (2006).
   Google Scholar
• Evans A, Tolonen H, Hense HW, Ferrario M, Sans S, Kuulasmaa K. WHO MONICA Project. Trends in coronary risk factors in the WHO MONICA Project. Int. J. Epidemiol. 30, S35–S40 (2001).
   Google Scholar
• Balkau B, Deanfield JE, Després JP et al. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 116, 1942–1951 (2007).
   Google Scholar
• Examination Committee of Criteria for ‘Obesity Disease’ in Japan; Japan Society for the Study of Obesity. New criteria for ‘obesity disease’ in Japan. Circ. J. 66, 987–992 (2002).
   Google Scholar
• Hiuge-Shimizu A, Kishida K, Funahashi T et al. Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study). Ann. Med. 44, 82–92 (2012). ▪ Relationship between visceral fat area measured by CT scans and obesity-related cardiovascular risk factors in the Japanese general population.
   Google Scholar
• Hiuge-Shimizu A, Kishida K, Funahashi T et al. Coexistence of visceral fat and multiple risk factor accumulations is strongly associated with coronary artery disease in Japanese (The VACATION-J Study). J. Atheroscler. Thromb. 19(7), 657–663 (2012). ▪ Relationship between visceral fat area measured by CT scans, multiple risk factors and coronary artery disease in the Japanese general population.
   Google Scholar
• Hiuge-Shimizu A, Kishida K, Funahashi T et al. Reduction of visceral fat correlates with the decrease in the number of obesity-related cardiovascular risk factors in Japanese with abdominal obesity (VACATION-J study). J. Atheroscler. Thromb. doi: http://dx.doi.org/10.5551/jat.12963 (2012) (Epub ahead of print). ▪ Reduction of visceral fat decreases the number of obesity-related cardiovascular risk factors in Japanese subjects with abdominal obesity.
   Google Scholar
• Fox CS, Massaro JM, Hoffmann U et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116, 39–48 (2007).
   Google Scholar
• Porter SA, Massaro JM, Hoffmann U, Vasan RS, O’Donnel CJ, Fox CS. Abdominal subcutaneous adipose tissue: a protective fat depot? Diabetes Care 32, 1068–1075 (2009).
   Google Scholar
• Nakamura T, Tokunaga K, Shimomura I et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis 107, 239–246 (1994).
   Google Scholar
• Cullen P, Schulte H, Assmann G. Smoking, lipoproteins and coronary heart disease risk. Data from the Münster Heart Study (PROCAM). Eur. Heart J. 19, 1632–1641 (1998).
   Google Scholar
• Kishida K, Funahashi T, Matsuzawa Y, Shimomura I. Visceral adiposity as a target for the management of the metabolic syndrome. Ann. Med. 44, 233–241 (2012). ▪ Visceral adiposity as a target for the management of the metabolic syndrome; Japanese perspective.
   Google Scholar
• Flack JM, Ensrud KE, Mascioli S et al. Racial and ethnic modifiers of the salt-blood pressure response. Hypertension 17(Suppl. 1), L115–L121 (1991).
   Google Scholar
• Douglas JG, Thibonnier M, Wright JT Jr. Essential hypertension: racial/ethnic differences in pathophysiology. J. Assoc. Acad. Minor Phys. 7, 16–21 (1996).
   Google Scholar
• Brownley KA, Hurwitz BE, Schneiderman N. Ethnic variations in the pharmacological and nonpharmacological treatment of hypertension: biopsychosocial perspective. Hum. Biol. 71, 607–639 (1999).
   Google Scholar
• Fujimoto WY, Akanuma Y, Kanazawa Y, Mashiko S, Leonetti D, Wahl P. Plasma insulin levels in Japanese and Japanese-American men with Type 2 diabetes may be related to the occurrence of cardiovascular disease. Diabetes Res. Clin. Pract. 6, 121–127 (1989).
   Google Scholar
• Chen KW, Boyko EJ, Bergstrom RW et al. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-year follow-up of initially nondiabetic Japanese-American men. Diabetes Care 18, 747–753 (1995).
   Google Scholar
• Fujimoto WY. Overview of non-insulindependent diabetes mellitus (NIDDM) in different population groups. Diabet. Med. 13, S7–S10 (1996).
   Google Scholar
• Singh V, Deedwania P. Dyslipidemia in special populations: Asian Indians, African Americans, and Hispanics. Curr. Atheroscler. Rep. 8, 32–40 (2006).
   Google Scholar
• Goff DC Jr, Bertoni AG, Kramer H et al. Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation 113, 647–656 (2006).
   Google Scholar
• Okauchi Y, Nishizawa H, Funahashi T et al. Reduction of visceral fat is associated with decrease in the number of metabolic risk factors in Japanese men. Diabetes Care 30, 2392–2394 (2007).
   Google Scholar
• Tamba S, Nishizawa H, Funahashi T et al. Relationship between the serum uric acid level, visceral fat accumulation and serum adiponectin concentration in Japanese men. Intern. Med. 47, 1175–1180 (2008).
   Google Scholar
• Okauchi Y, Kishida K, Funahashi T et al. Changes in serum adiponectin concentrations correlate with changes in BMI, waist circumference, and estimated visceral fat area in middle-aged general population. Diabetes Care 32, e122 (2009).
   Google Scholar
• Tamba S, Nakatsuji H, Kishida K et al. Relationship between visceral fat accumulation and urinary albumincreatinine ratio in middle-aged Japanese men. Atherosclerosis 211, 601–605 (2010).
   Google Scholar
• Nakatsuji H, Kishida K, Funahashi T et al. One-year reductions in body weight and blood pressure, but not in visceral fat accumulation and adiponectin, improve urinary albumin-to-creatinine ratio in middle-aged Japanese men. Diabetes Care 33, e110–e111 (2010).
   Google Scholar
• Okauchi Y, Kishida K, Funahashi T et al. 4-year follow-up of cardiovascular events and changes in visceral fat accumulation after health promotion program in the Amagasaki Visceral Fat Study. Atherosclerosis 212, 698–700 (2010). ▪▪ Reduction of visceral fat through health promotion program prevents cardiovascular events in Japanese subjects with abdominal obesity.
   Google Scholar
• Okauchi Y, Kishida K, Funahashi T et al. Absolute value of bioelectrical impedance analysis-measured visceral fat area with obesity-related cardiovascular risk factors in Japanese workers. J. Atheroscler. Thromb. 17, 1237–1245 (2010).
   Google Scholar
• Ryo M, Nakamura T, Funahashi T et al. Health education “Hoken-shido” program reduced metabolic syndrome in the Amagasaki visceral fat study. Three-year follow-up study of 3,174 Japanese employees. Intern. Med. 50, 1643–1648 (2011).
   Google Scholar
• Okauchi Y, Kishida K, Funahashi T et al. Cross-sectional and longitudinal study of association between circulating thiobarbituric acid-reacting substance levels and clinicobiochemical parameters in 1,178 middle-aged Japanese men – the Amagasaki Visceral Fat Study. Nutr. Metab. (Lond.) 8, 82 (2011).
   Google Scholar
• Kishida K, Funahashi T, Shimomura I. Clinical significance of visceral fat reduction through health education in preventing atherosclerotic cardiovascular disease – lesson from the Amagasaki Visceral Fat Study: a Japanese perspective. Nutr. Metab. (Lond.) 16(8), 57 (2011). ▪▪ Clinical significance of visceral fat reduction through voluntary lifestyle modification by health education in preventing atherosclerotic cardiovascular disease.
   Google Scholar
• Matsuzawa Y, Shimomura I, Nakamura T, Keno Y, Kotani K, Tokunaga K. Pathophysiology and pathogenesis of visceral fat obesity. Obes. Res. 3, S187–S194 (1995).
   Google Scholar
• Matsuzawa Y. Pathophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experience. Diabetes Metab. Rev. 13, 3–13 (1997).
   Google Scholar
• Lafontan M, Girard J. Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue. Diabetes Metab. 34(4 Pt 1), 317–327 (2008).
   Google Scholar
• Jensen MD. Role of body fat distribution and the metabolic complications of obesity. J. Clin. Endocrinol. Metab. 93, S57–S63 (2008).
   Google Scholar
• Kuriyama H, Yamashita S, Shimomura I et al. Enhanced expression of hepatic acyl-coenzyme A synthetase and microsomal triglyceride transfer protein messenger RNAs in the obese and hypertriglyceridemic rat with visceral fat accumulation. Hepatology 27, 557–562 (1998).
   Google Scholar
• Kuriyama H, Shimomura I, Kishida K et al. Coordinated regulation of fat-specific and liver-specific glycerol channels, aquaporin adipose and aquaporin 9. Diabetes 51, 2915–2921 (2002).
   Google Scholar
• Maeda N, Funahashi T, Shimomura I. Metabolic impact of adipose and hepatic glycerol channels aquaporin 7 and aquaporin 9. Nat. Clin. Pract. Endocrinol. Metab. 4, 627–634 (2008).
   Google Scholar
• Teramoto T, Sasaki J, Ueshima H et al. Metabolic syndrome. J. Atheroscler. Thromb. 15, 1–5 (2008).
   Google Scholar
• Maeda K, Okubo K, Shimomura I, Mizuno K, Matsuzawa Y, Matsubara K. Analysis of an expression profile of genes in the human adipose tissue. Gene 190, 227–235 (1997).
   Google Scholar
• Funahashi T, Nakamura T, Shimomura I et al. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern. Med. 38, 202–206 (1999). ▪▪ Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity.
   Google Scholar
• Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem. Biophys. Res. Commun. 22, 286–289 (1996).
   Google Scholar
• Matsuzawa Y. Establishment of a concept of visceral fat syndrome and discovery of adiponectin. Proc. Jpn Acad. Ser. B. Phys. Biol Sci. 86, 131–141 (2010).
   Google Scholar
• Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol Chem. 270, 26746–26749 (1995).
   Google Scholar
• Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol Chem. 271, 10697–10703 (1996).
   Google Scholar
• Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M. Isolation and characterization of GBP28, a novel gelatinbinding protein purified from human plasma. J. Biochem. 120, 803–812 (1996).
   Google Scholar
• Frayn KN, Arner P, Yki-Järvinen H. Fatty acid metabolism in adipose tissue, muscle and liver in health and disease. Essays Biochem. 42, 89–103 (2006).
   Google Scholar
• Goossens GH. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol. Behav. 94, 206–218 (2008).
   Google Scholar
• Lettner A, Roden M. Ectopic fat and insulin resistance. Curr. Diab. Rep. 8, 185–191 (2008).
   Google Scholar
• Mittendorfer B. Origins of metabolic complications in obesity: adipose tissue and free fatty acid trafficking. Curr. Opin Clin. Nutr. Metab. Care 14, 535–541 (2011).
   Google Scholar
• Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat. Clin. Pract. Cardiovasc. Med. 2, 536–543 (2005).
   Google Scholar
• Rabkin SW. Epicardial fat: properties, function and relationship to obesity. Obes. Rev. 8, 253–261 (2007).
   Google Scholar
• Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am. Heart J. 153, 907–917 (2007).
   Google Scholar
• Iozzo P. Myocardial, perivascular, and epicardial fat. Diabetes Care 34, S371–S379 (2011).
   Google Scholar
• Verhagen SN, Visseren FL. Perivascular adipose tissue as a cause of atherosclerosis. Atherosclerosis 214, 3–10 (2011).
   Google Scholar
• Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea–hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365, 1046–1053 (2005).
   Google Scholar
• Barbé F, Durán-Cantolla J, Sánchez-de-la-Torre M et al. Spanish Sleep And Breathing Network. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA 307, 2161–2268 (2012).
   Google Scholar
• Shinohara E, Kihara S, Yamashita S et al. Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects. J. Intern. Med. 241, 11–18 (1997).
   Google Scholar
• Schäfer H, Pauleit D, Sudhop T, Gouni-Berthold I, Ewig S, Berthold HK. Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 122, 829–839 (2002).
   Google Scholar
• Vgontzas AN, Bixler EO, Chrousos GP. Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. J. Intern. Med. 254, 32–44 (2003).
   Google Scholar
• Nakagawa Y, Kishida K, Kihara S et al. Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apneahypopnea syndrome. Am. J. Physiol. Endocrinol. Metab. 294, e778–e784 (2008).
   Google Scholar
• Nakagawa Y, Kishida K, Kihara S, Yoshida R, Funahashi T, Shimomura I. Nocturnal falls of adiponectin levels in sleep apnea with abdominal obesity and impact of hypoxia-induced dysregulated adiponectin production in obese murine mesenteric adipose tissue. J. Atheroscler. Thromb. 18, 240–247 (2011).
   Google Scholar